Peter Bialek

3.9k total citations · 3 hit papers
18 papers, 3.1k citations indexed

About

Peter Bialek is a scholar working on Molecular Biology, Genetics and Rheumatology. According to data from OpenAlex, Peter Bialek has authored 18 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Genetics and 3 papers in Rheumatology. Recurrent topics in Peter Bialek's work include Muscle Physiology and Disorders (6 papers), Bone Metabolism and Diseases (5 papers) and TGF-β signaling in diseases (2 papers). Peter Bialek is often cited by papers focused on Muscle Physiology and Disorders (6 papers), Bone Metabolism and Diseases (5 papers) and TGF-β signaling in diseases (2 papers). Peter Bialek collaborates with scholars based in United States, United Kingdom and Canada. Peter Bialek's co-authors include Gérard Karsenty, Hans Clevers, Donald A. Glass, Millan S. Patel, Mark M. Taketo, Andrew P. McMahon, Richard A. Lang, Jong Deok Ahn, Michael W. Starbuck and Fanxin Long and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Genes & Development.

In The Last Decade

Peter Bialek

17 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Canonical Wnt Signaling in Differentiated Osteoblasts Controls Osteoclast Differentiation

2005 1.2k citations Donald A. Glass, Peter Bialek et al. Developmental Cell profile →
ATF4 Is a Substrate of RSK2 and an Essential Regulator of Osteoblast Biology

2004 653 citations Xiangli Yang, Koichi Matsuda et al. Cell profile →
A Twist Code Determines the Onset of Osteoblast Differentiation

2004 532 citations Peter Bialek, Xiangli Yang et al. Developmental Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Bialek United States	14	2.4k	731	540	360	349	18	3.1k
Anders Thornell Sweden	17	2.4k 1.0×	857 1.2×	501 0.9×	501 1.4×	385 1.1×	29	3.6k
Donald A. Glass United States	16	2.3k 1.0×	770 1.1×	552 1.0×	256 0.7×	189 0.5×	38	3.3k
Tatsuya Furuichi Japan	23	2.1k 0.9×	676 0.9×	482 0.9×	695 1.9×	558 1.6×	40	3.2k
Takuma Matsubara Japan	21	2.5k 1.0×	989 1.4×	262 0.5×	506 1.4×	576 1.7×	58	3.2k
Su‐Li Cheng United States	32	2.4k 1.0×	682 0.9×	732 1.4×	635 1.8×	274 0.8×	53	4.4k
Jennifer J. Westendorf United States	23	2.5k 1.1×	792 1.1×	339 0.6×	272 0.8×	474 1.4×	31	3.2k
Courtney M. Karner United States	30	2.4k 1.0×	411 0.6×	626 1.2×	186 0.5×	423 1.2×	54	3.2k
P. Joseph Mee United Kingdom	15	2.0k 0.8×	808 1.1×	555 1.0×	203 0.6×	298 0.9×	20	4.3k
Angela Denzel United Kingdom	10	2.5k 1.0×	905 1.2×	378 0.7×	500 1.4×	436 1.2×	13	3.2k
Jian Q. Feng United States	17	2.0k 0.8×	959 1.3×	300 0.6×	475 1.3×	291 0.8×	27	2.8k

Countries citing papers authored by Peter Bialek

Since Specialization

Citations

This map shows the geographic impact of Peter Bialek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Bialek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Bialek more than expected).

Fields of papers citing papers by Peter Bialek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Bialek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Bialek. The network helps show where Peter Bialek may publish in the future.

Co-authorship network of co-authors of Peter Bialek

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Bialek. A scholar is included among the top collaborators of Peter Bialek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Bialek. Peter Bialek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Antonijevic, Irina, Brian R. Bettencourt, Peter Bialek, et al.. (2022). Suppression of Somatic Expansion As a Novel Therapeutic Approach for Huntington Disease and Other Repeat Expansion Disorders. ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam). 1(2). 163–175. 1 indexed citations

Fulton, Graham R. & Peter Bialek. (2018). The Chevert: A History. Journal of Pacific History. 53(2). 186–200.

Johnson, M. Catherine, Prashant Bansal, Jeremy Wellen, et al.. (2017). A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys. Skeletal Muscle. 7(1). 78 indexed citations

Woo, Caroline J., Verena Maier, James F. Brennan, et al.. (2017). Gene activation of SMN by selective disruption of lncRNA-mediated recruitment of PRC2 for the treatment of spinal muscular atrophy. Proceedings of the National Academy of Sciences. 114(8). E1509–E1518. 69 indexed citations

Apgar, James R., Susan Benard, Peter Bialek, et al.. (2016). Beyond CDR-grafting: Structure-guided humanization of framework and CDR regions of an anti-myostatin antibody. mAbs. 8(7). 1302–1318. 34 indexed citations

Ebner, David C., Peter Bialek, Ayman El‐Kattan, Catherine M. Ambler, & Meihua Tu. (2014). Strategies for Skeletal Muscle Targeting in Drug Discovery. Current Pharmaceutical Design. 21(10). 1327–1336. 20 indexed citations

Bialek, Peter, et al.. (2013). A myostatin and activin decoy receptor enhances bone formation in mice. Bone. 60. 162–171. 85 indexed citations

Arounleut, Phonepasong, Peter Bialek, Sunil Upadhyay, et al.. (2013). A myostatin inhibitor (propeptide-Fc) increases muscle mass and muscle fiber size in aged mice but does not increase bone density or bone strength. Experimental Gerontology. 48(9). 898–904. 55 indexed citations

Bialek, Peter, Carl Morris, Jascha Parkington, et al.. (2011). Distinct protein degradation profiles are induced by different disuse models of skeletal muscle atrophy. Physiological Genomics. 43(19). 1075–1086. 49 indexed citations

10.

Bialek, Peter, Jascha Parkington, Jian Li, et al.. (2008). Mice treated with a myostatin/GDF-8 decoy receptor, ActRIIB-Fc, exhibit a tremendous increase in bone mass. Bone. 42. S46–S46. 12 indexed citations

11.

Galler, Kerstin M., Akihiro Yasue, Adriana Cavender, et al.. (2007). A Novel Role for Twist-1 in Pulp Homeostasis. Journal of Dental Research. 86(10). 951–955. 16 indexed citations

12.

Hinoi, Eiichi, Peter Bialek, You‐Tzung Chen, et al.. (2006). Runx2 inhibits chondrocyte proliferation and hypertrophy through its expression in the perichondrium. Genes & Development. 20(21). 2937–2942. 129 indexed citations

13.

Glass, Donald A., Peter Bialek, Jong Deok Ahn, et al.. (2005). Canonical Wnt Signaling in Differentiated Osteoblasts Controls Osteoclast Differentiation. Developmental Cell. 8(5). 751–764. 1234 indexed citations breakdown →

14.

Watson, Carole, Peter Bialek, Makoto Anzo, et al.. (2005). Elevated Circulating Insulin-Like Growth Factor Binding Protein-1 Is Sufficient to Cause Fetal Growth Restriction. Endocrinology. 147(3). 1175–1186. 54 indexed citations

15.

Bialek, Peter, Xiangli Yang, Dražen Šošić, et al.. (2004). A Twist Code Determines the Onset of Osteoblast Differentiation. Developmental Cell. 6(3). 423–435. 532 indexed citations breakdown →

16.

Yang, Xiangli, Koichi Matsuda, Peter Bialek, et al.. (2004). ATF4 Is a Substrate of RSK2 and an Essential Regulator of Osteoblast Biology. Cell. 117(3). 387–398. 653 indexed citations breakdown →

17.

Varghese, Robin, et al.. (2002). Overexpression of Human Stanniocalcin Affects Growth and Reproduction in Transgenic Mice. Endocrinology. 143(3). 868–876. 102 indexed citations

18.

Bialek, Peter, et al.. (2000). Characterization of a Novel Insertional Mouse Mutation, kkt: A Closely Linked Modifier of Pax1. Developmental Biology. 218(2). 354–366. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact